Introducing Acceptitol, for facts you cannot comfortably metabolize

Acceptitol is a fictional launch built for the exact moment a problem stops being a problem and starts becoming a branding opportunity.

The condition

A patient-facing refusal to process the most inconvenient line on the label.

Common symptoms

Repeated requests for a manager after reading a normal policy. Selective hearing when the answer is “no.” A sudden allergy to personal responsibility.

How it allegedly works

Selectively binds to inconvenient conclusions, allowing patients to acknowledge reality without displaying any measurable change in behavior.

Clinical trial results

Participants showed a 78% reduction in dramatic follow-up emails. One in four subjects apologized without a qualifying clause. All participants were still themselves, which remains under review.

Michael has spent 17 years ensuring that every claim is followed by a smaller, less reassuring claim.

This fictional product is not medicine, medical advice, a substitute for professional care, or particularly defensible in a regulatory meeting.